Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
8
|
| gptkbp:bfsParent |
gptkb:Muscular_Dystrophy
|
| gptkbp:affects |
muscles
|
| gptkbp:associated_with |
gptkb:historical_event
gptkb:Company anxiety fatigue sleep disturbances social isolation pain vision problems hearing loss joint pain difficulty swallowing sleep apnea muscle stiffness increased risk of infections muscle hypertrophy cognitive impairment dysphagia muscle cramps skin problems muscle wasting dysarthria endocrine disorders sensitivity to heat hypotonia scoliosis hypersomnia hyperreflexia increased risk of falls sensitivity to cold facial weakness increased risk of fractures increased risk of complications during pregnancy increased risk of complications during surgery increased risk of complications in anesthesia |
| gptkbp:caused_by |
DMPK gene mutation
|
| gptkbp:complications |
mental health issues
respiratory failure infertility cardiac arrhythmias gastrointestinal issues |
| gptkbp:descendant |
autosomal dominant
|
| gptkbp:discovered_by |
Hans Gustav Adolf Steinert
|
| gptkbp:first_described_by |
1909
|
| gptkbp:genetic_diversity |
recommended
|
| https://www.w3.org/2000/01/rdf-schema#label |
Myotonic Dystrophy
|
| gptkbp:is_often_used_in |
adults
both genders |
| gptkbp:is_popular_in |
1 in 8000
|
| gptkbp:lifespan |
normal with management
|
| gptkbp:research |
ongoing
|
| gptkbp:social_responsibility |
genetic testing
|
| gptkbp:symptoms |
muscle weakness
cataracts cardiac issues myotonia |
| gptkbp:treatment |
medications
physical therapy |
| gptkbp:type_of |
Myotonic Dystrophy type 1
Myotonic Dystrophy type 2 |